Literature DB >> 29449422

Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation.

Aurélien Justet1,2, Gabriel Thabut2,3, Effrosyni Manali4, Maria Molina Molina5, Caroline Kannengiesser6, Jacques Cadranel7, Vincent Cottin8, Anne Gondouin9, Hilario Nunes10, Eline Magois11, Cécile Tromeur12, Grégoire Prevot13, Spyros Papiris4, Sylvain Marchand-Adam14, Anne Sophie Gamez15, Martine Reynaud-Gaubert16, Lidwine Wemeau17, Bruno Crestani1,2, Raphael Borie18,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29449422     DOI： 10.1183/13993003.01875-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  9 in total

Review 1.  Telomeres in Interstitial Lung Disease: The Short and the Long of It.

Authors:  Andrew M Courtwright; Souheil El-Chemaly
Journal:  Ann Am Thorac Soc       Date:  2019-02

2.  Familial pulmonary fibrosis: a world without frontiers.

Authors:  Raphael Borie; Bruno Crestani
Journal:  J Bras Pneumol       Date:  2019-10-07       Impact factor: 2.624

Review 3.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819

4.  Compound heterozygous mutation of RTEL1 in interstitial lung disease complicated with pneumothorax and emphysema: A case report and literature review.

Authors:  Man Luo; Jiao-Li Wang
Journal:  Respirol Case Rep       Date:  2022-09-06

Review 5.  Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis.

Authors:  Hongbo Ma; Xuyi Wu; Yi Li; Yong Xia
Journal:  Front Pharmacol       Date:  2022-07-21       Impact factor: 5.988

6.  Dyspnoea with progressive "idiopathic" pulmonary fibrosis.

Authors:  Chahat Puri; Vignesh Harish; Kyunghoon Rhee; Donald F Slack
Journal:  Respirol Case Rep       Date:  2021-06-06

7.  Diverse Pathological Findings of Interstitial Lung Disease in a Patient with Dyskeratosis Congenita.

Authors:  Ryota Otoshi; Tomohisa Baba; Ryota Shintani; Hideya Kitamura; Yukie Yamaguchi; Haruka Hamanoue; Takeshi Mizuguchi; Naomichi Matsumoto; Koji Okudela; Tamiko Takemura; Takashi Ogura
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

8.  Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review.

Authors:  Ping Wang; Zuojun Xu
Journal:  BMC Pulm Med       Date:  2021-09-03       Impact factor: 3.317

Review 9.  Telomeres in Interstitial Lung Disease.

Authors:  Carmel J W Stock; Elisabetta A Renzoni
Journal:  J Clin Med       Date:  2021-03-30       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.